GoodRx Holdings, Inc.
GDRX
$4.01
-$0.26-6.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.35% | 5.61% | 7.14% | 4.03% | 2.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.35% | 5.61% | 7.14% | 4.03% | 2.27% |
| Cost of Revenue | -15.61% | -22.76% | -32.44% | -20.74% | -16.25% |
| Gross Profit | 6.00% | 8.18% | 11.23% | 6.51% | 4.17% |
| SG&A Expenses | -3.70% | 0.27% | 10.69% | 11.08% | 2.78% |
| Depreciation & Amortization | 20.23% | 14.06% | -40.51% | 3.83% | 7.32% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.02% | -1.02% | -5.09% | 3.29% | -1.55% |
| Operating Income | 80.39% | 98.31% | 287.64% | 13.57% | 90.24% |
| Income Before Tax | 181.25% | 156.61% | 87.15% | -422.35% | -75.33% |
| Income Tax Expenses | 137.07% | 132.27% | 122.94% | 97.33% | -452.54% |
| Earnings from Continuing Operations | 531.93% | 284.82% | -207.92% | -597.70% | 86.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 531.93% | 284.82% | -207.92% | -597.70% | 86.39% |
| EBIT | 80.39% | 98.31% | 287.64% | 13.57% | 90.24% |
| EBITDA | 28.75% | 29.26% | 57.72% | 14.86% | 44.61% |
| EPS Basic | 533.53% | 290.75% | -205.18% | -595.12% | 85.25% |
| Normalized Basic EPS | 128.68% | 169.46% | 1,343.75% | 27.21% | 477.42% |
| EPS Diluted | 474.87% | 269.57% | -232.65% | -764.02% | 83.69% |
| Normalized Diluted EPS | 127.24% | 167.65% | 1,350.53% | 26.57% | 476.34% |
| Average Basic Shares Outstanding | -6.31% | -6.93% | -6.09% | -4.02% | -1.83% |
| Average Diluted Shares Outstanding | -5.22% | -5.88% | -5.17% | -3.63% | -1.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |